Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-11-19 4:10 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | INTEGRATED CORE STRATEGIES (US) LLC | 2,004,338 4.9% | 1,215,638 (+154.13%) | View |
| 2021-11-10 4:08 pm Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | ALGER ASSOCIATES INC | 890,396 2.18% | -2,525,607 (-73.93%) | View |
| 2021-02-16 4:51 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | ALGER ASSOCIATES INC | 3,416,003 8.59% | 3,416,003 (New Position) | View |
| 2021-02-16 08:21 am Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | Camber Capital Management LP | 2,555,000 6.43% | 155,000 (+6.46%) | View |
| 2021-02-12 3:58 pm Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | EcoR1 Capital LLC | 0 0% | -2,536,156 (Position Closed) | View |
| 2021-02-12 12:30 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | Flynn James E | 3,959,741 9.96% | 1,681,588 (+73.81%) | View |
| 2021-02-10 3:13 pm Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | STATE STREET CORP STT | 2,242,037 5.64% | -1,265,115 (-36.07%) | View |
| 2021-02-10 11:40 am Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | VANGUARD GROUP INC | 3,396,689 8.54% | -589,437 (-14.79%) | View |
| 2021-02-09 4:37 pm Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | INTEGRATED CORE STRATEGIES (US) LLC | 788,700 2% | -1,161,606 (-59.56%) | View |
| 2021-01-29 5:23 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | BlackRock Inc. BLK | 2,996,015 7.5% | 104,679 (+3.62%) | View |
| 2020-08-10 2:52 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | Flynn James E | 2,278,153 5.74% | 2,278,153 (New Position) | View |
| 2020-06-29 6:03 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | Camber Capital Management LP | 2,400,000 6.1% | 2,400,000 (New Position) | View |
| 2020-03-26 4:21 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | EcoR1 Capital LLC | 2,536,156 6.5% | 2,536,156 (New Position) | View |
| 2020-02-14 4:05 pm Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | PFM Health Sciences LP | 0 0% | -2,629,956 (Position Closed) | View |
| 2020-02-14 12:00 pm Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | ORBIMED ADVISORS LLC | 0 0% | -2,063,837 (Position Closed) | View |
| 2020-02-13 12:23 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | STATE STREET CORP STT | 3,507,152 9% | 681,537 (+24.12%) | View |
| 2020-02-11 7:29 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | VANGUARD GROUP INC | 3,986,126 10.23% | 80,603 (+2.06%) | View |
| 2020-02-05 12:15 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | BlackRock Inc. BLK | 2,891,336 7.4% | 225,450 (+8.46%) | View |
| 2020-02-03 4:55 pm Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | INTEGRATED CORE STRATEGIES (US) LLC | 1,950,306 5% | -9,194 (-0.47%) | View |
| 2019-11-20 4:53 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | INTEGRATED CORE STRATEGIES (US) LLC | 1,959,500 5% | 1,959,500 (New Position) | View |